William T. Jorgensen
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma.
Journal: Nature communications
Published: October 17, 2024
Structure-Activity Relationships, Deuteration, and Fluorination of Synthetic Cannabinoid Receptor Agonists Related to AKB48, 5F-AKB-48, and AFUBIATA.
Journal: ACS chemical neuroscience
Published: May 20, 2024
Understanding In Vitro Pathways to Drug Discovery for TDP-43 Proteinopathies.
Journal: International journal of molecular sciences
Published: October 07, 2022
P2X receptor antagonists and their potential as therapeutics: a patent review (2010-2021).
Journal: Expert opinion on therapeutic patents
Published: April 20, 2022
Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (CaV3) Inhibitors.
Journal: ACS chemical neuroscience
Published: April 20, 2022
Update to Our Reader, Reviewer, and Author Communities-April 2020.
Journal: ACS chemical neuroscience
Published: April 23, 2020
Targeting the Oxytocin System: New Pharmacotherapeutic Approaches.
Journal: Trends in pharmacological sciences
Published: July 30, 2018
Conformationally rigid derivatives of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin-1a receptors.
Journal: European journal of medicinal chemistry
Published: July 11, 2017
Investigation of pyrazolo-sulfonamides as putative small molecule oxytocin receptor agonists.
Journal: European journal of medicinal chemistry
Published: December 16, 2016
Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1a receptors.
Journal: European journal of medicinal chemistry
Published: October 29, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026